We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Skin Aging in Renal Transplant Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01776983
Recruitment Status : Completed
First Posted : January 28, 2013
Last Update Posted : June 16, 2015
Sponsor:
Information provided by (Responsible Party):
University of Zurich

Brief Summary:

Determination of collagen, pigment and haemoglobin content of sun exposed and sun protected skin by Siascopy. Immunocompromised patients (for more than seven years) compared to immunocompetent patients.

  • Trial in the field of transplantation / xenotransplantation

Condition or disease Intervention/treatment Phase
Photosensitivity Disorders Device: Photosensitivity under the influence of immunocomp Phase 4

Detailed Description:
Determination of collagen, pigment and haemoglobin content of sun exposed and sun protected skin by Siascopy. Immunocompromised patients (for more than seven years) compared to immunocompetent patients.

Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Cohort
Official Title: Skin Aging in Renal Transplant Patients
Study Start Date : September 2008
Primary Completion Date : November 2013
Study Completion Date : January 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Skin Aging
U.S. FDA Resources


Intervention Details:
    Device: Photosensitivity under the influence of immunocomp
    Siascopy measurement of reflected light


Primary Outcome Measures :
  1. skin aging defined by melanin, collagen and hemoglobin content [ Time Frame: One Time measurement at the one and only time point of inclusion and measurement ]
    there is only one time point for measurement, there is no "time frame", just one single measurement per patient at the one and only visit



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
individuals between 18 and 90 years of age
Criteria

Inclusion criteria:

  • Renal transplant recipients transplanted more than seven years ago and immunocompetent probands of the same age.

Exclusion criteria:

  • Refusal of informed consent, physical or psychological inability to give informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01776983


Locations
Switzerland
University Hospital Zurich, Department of Dermatology
Zurich, ZH, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Günther Hofbauer, MD University Hospital Zurich, Department of Dermatology

Publications:
Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01776983     History of Changes
Other Study ID Numbers: 2008SIA01
First Posted: January 28, 2013    Key Record Dates
Last Update Posted: June 16, 2015
Last Verified: June 2015

Additional relevant MeSH terms:
Photosensitivity Disorders
Skin Diseases